ATE323767T1 - Impfstoff für die infektiöse peritonitis der katzen - Google Patents

Impfstoff für die infektiöse peritonitis der katzen

Info

Publication number
ATE323767T1
ATE323767T1 AT95929143T AT95929143T ATE323767T1 AT E323767 T1 ATE323767 T1 AT E323767T1 AT 95929143 T AT95929143 T AT 95929143T AT 95929143 T AT95929143 T AT 95929143T AT E323767 T1 ATE323767 T1 AT E323767T1
Authority
AT
Austria
Prior art keywords
vaccine
infectious peritonitis
gene
plasmids
expression
Prior art date
Application number
AT95929143T
Other languages
English (en)
Inventor
Rapha L Darteil
Wayne Corapi
Jean-Chirstophe Audonnet
Gilles-Emile Chappuis
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9466540&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE323767(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of ATE323767T1 publication Critical patent/ATE323767T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Business, Economics & Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Business, Economics & Management (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT95929143T 1994-08-29 1995-08-28 Impfstoff für die infektiöse peritonitis der katzen ATE323767T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9410379A FR2724385B1 (fr) 1994-08-29 1994-08-29 Vaccin de la peritonite infectieuse feline.

Publications (1)

Publication Number Publication Date
ATE323767T1 true ATE323767T1 (de) 2006-05-15

Family

ID=9466540

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95929143T ATE323767T1 (de) 1994-08-29 1995-08-28 Impfstoff für die infektiöse peritonitis der katzen

Country Status (13)

Country Link
US (3) US6080850A (de)
EP (1) EP0778894B1 (de)
JP (1) JPH10505236A (de)
AT (1) ATE323767T1 (de)
AU (1) AU686000B2 (de)
BR (1) BR9508645B1 (de)
CA (1) CA2198743C (de)
DE (1) DE69534945T2 (de)
DK (1) DK0778894T3 (de)
ES (1) ES2264128T3 (de)
FR (1) FR2724385B1 (de)
PT (1) PT778894E (de)
WO (1) WO1996006934A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751223B1 (fr) * 1996-07-19 1998-12-04 Rhone Merieux Formule de vaccin polynucleotidique felin
AU5530498A (en) * 1996-12-18 1998-07-15 Synbiotics Corporation A specific diagnostic for antibodies to feline infectious peritonitis virus
FR2828405B1 (fr) * 2001-08-09 2005-06-24 Virbac Sa Vaccin anti-coronavirus
RU2249451C2 (ru) * 2003-01-05 2005-04-10 Дагестанская государственная медицинская академия Способ лечения острого гнойного воспаления в серозной полости
US8080642B2 (en) * 2003-05-16 2011-12-20 Vical Incorporated Severe acute respiratory syndrome DNA compositions and methods of use
AU2013221502C1 (en) 2012-02-14 2018-03-01 Boehringer Ingelheim Animal Health USA Inc. Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom
CN116808193B (zh) * 2023-08-29 2023-11-14 成都导飞科技有限公司 一种用于预防猫传染性腹膜炎的重组蛋白疫苗及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0264979A1 (de) * 1986-09-05 1988-04-27 Duphar International Research B.V Proteine und Peptide, wirksam wie Antigen und Impfstoffe gegen das infektiöse Peritonitisvirus der Felides (FIPV)
US5410472A (en) * 1989-03-06 1995-04-25 Ergometrx Corporation Method for conditioning or rehabilitating using a prescribed exercise program
WO1991008525A1 (fr) * 1989-11-28 1991-06-13 Toyo Seikan Kaisha, Ltd. Recipient metallique equipe d'un hologramme ou d'un reseau de diffraction
WO1993023421A1 (en) * 1992-05-08 1993-11-25 Smithkline Beecham Corporation Universal coronavirus vaccine
GB2316681B (en) * 1993-09-16 1998-04-15 Dimminaco Ag Sa Ltd Antigenically active proteins/polypeptides and coronavirus vaccines containing the same

Also Published As

Publication number Publication date
AU3261295A (en) 1996-03-22
BR9508645B1 (pt) 2009-01-13
EP0778894A1 (de) 1997-06-18
FR2724385B1 (fr) 1996-12-13
DE69534945D1 (de) 2006-05-24
AU686000B2 (en) 1998-01-29
PT778894E (pt) 2006-08-31
CA2198743C (en) 2009-02-10
US6358512B1 (en) 2002-03-19
ES2264128T3 (es) 2006-12-16
DE69534945T2 (de) 2007-02-01
FR2724385A1 (fr) 1996-03-15
US6096535A (en) 2000-08-01
DK0778894T3 (da) 2006-08-07
US6080850A (en) 2000-06-27
JPH10505236A (ja) 1998-05-26
BR9508645A (pt) 1997-12-23
CA2198743A1 (en) 1996-03-07
EP0778894B1 (de) 2006-04-19
WO1996006934A1 (fr) 1996-03-07

Similar Documents

Publication Publication Date Title
ATE420190T1 (de) Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen
PT783321E (pt) Sequencia nucleotidica viral vr-2332 e metodos de utilizacao
DE69737886D1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
AR042378A2 (es) Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de dicho poxvirus para preparar una vacuna eficaz contra la infeccion del virus de inmunodeficiencia felina
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
SG153874A1 (en) Neutralizing epitope-based growth enhancing vaccine
DE60310562D1 (de) Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
ATE328073T1 (de) Ehrlichia canis protein
MX9101042A (es) Adn y arn recombinantes y productos derivados de los mismos
ES2188605T3 (es) Virus poxvirales y su utilizacion como vacuna contra la enfermedad virica de la peritonitis infecciosa felina.
DE69534945D1 (de) Impfstoff für die infektiöse peritonitis der katzen
AR009365A1 (es) Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno
ATE543513T1 (de) Anti-coronavirus impfstoff
CY1116756T1 (el) Αιμοκυανινη και κωδικευουσα γι'αυτην ακολουθια νουκλεϊνικου οξεος
ES2073777T3 (es) Inhibicion de la replicacion virica.
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus
DE60042922D1 (de) Virale expressionsvektoren für pflanzen
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
DE50304603D1 (de) Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze
ATE511545T1 (de) Rekombinantes virus, das fremd-dna kodierend für katzen-cd80, katzen-cd28, katzen-ctla-4 oder katzen-cd86 exprimiert und seine verwendungen
Darteil et al. Feline infectious peritonitis vaccine
KR930701588A (ko) 재조합 구두 바이러스 백신
DE60229966D1 (de) Diabetesmodell
CY1108761T1 (el) Απενεργοποιημενες κυτοκινες για ανοσοποιηση
DE60136832D1 (de) Atcr-1, eine humane acyltransferase und verwendungen davon

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0778894

Country of ref document: EP